Schedule 13D ownership disclosure

ALZAMEND NEURO INC

Common Stock, par value $0.0001 per share · CUSIP: 02262M605

Event date: 2025-07-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MILTON C. AULT, IIIReported CIK 0001212502

    Shares: 706,322.00 · Class: 18.5%

  • WILLIAM B. HORNEReported CIK 0001333268

    Shares: 3,518.00 · Class: 0.1%

  • HENRY C.W. NISSERReported CIK 0001775938

    Shares: 926.00 · Class: 0.0%

  • KENNETH S. CRAGUNReported CIK 0001327261

    Shares: 1,111.00 · Class: 0.0%

  • DAVID J. KATZOFFReported CIK 0001864317

    Shares: 1,726.00 · Class: 0.1%

  • HYPERSCALE DATA, INC.Reported CIK 0000896493

    Shares: 693,349.00 · Class: 18.1%

  • AULT LENDING, LLC

    Shares: 693,337.00 · Class: 18.1%

  • AULT LIFE SCIENCES, INC.

    Shares: 11,068.00 · Class: 0.4%

  • AULT LIFE SCIENCES FUND, LLC

    Shares: 61.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-011394
Form type
SCHEDULE 13D/A
Filer
AULT MILTON C III
CIK
CIK 1212502
Filed
Aug 01, 2025
Reporting period
Jul 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub